These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8767620

  • 1. [Clinical experience in patients with chronic peripheral obliterating arteriopathy: defibrotide versus definite molecular weight heparan sulfate (MW 7500-15000 dalton)].
    Michelini S, Micci A, Failla A, Grechi G, Iantaffi A.
    Minerva Cardioangiol; 1996; 44(1-2):33-7. PubMed ID: 8767620
    [Abstract] [Full Text] [Related]

  • 2. Effects of defibrotide on physical performance and hemorheologic picture in patients with peripheral arteriopathy.
    Marrapodi E, Leanza D, Giordano S, Nazzari M, Corsi C.
    Clin Trials Metaanal; 1994 Apr; 29(1):21-30. PubMed ID: 10150182
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter, placebo-controlled, dose comparison study of orally administered defibrotide: preliminary results in patients with peripheral arterial disease.
    Strano A, Fareed J, Sabbá C, Albano O, Allegra C, Carlizza A, Binaghi F, Fronteddu F, Del Guercio R, Arpaia MR.
    Semin Thromb Hemost; 1991 Apr; 17 Suppl 2():228-34. PubMed ID: 1948094
    [Abstract] [Full Text] [Related]

  • 4. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease.
    Sabbá C, Zupo V, Dina F, Nazzari M, Albano O.
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):249-52. PubMed ID: 3045026
    [Abstract] [Full Text] [Related]

  • 5. Defibrotide and peripheral obliterative arterial disease: preliminary data.
    Arosio E, Pancera P, Zannoni M, Arcaro G, Priante F, Lechi A.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):526-9. PubMed ID: 2533180
    [Abstract] [Full Text] [Related]

  • 6. Effects of defibrotide after oral and parenteral administration in patients with peripheral obliterative arterial disease (POAD).
    Craveri A, Tornaghi G, Ranieri R, Stanzani M, Landi G, Paganardi L, Passaretti B, Gallo E.
    Int Angiol; 1990 Nov; 9(4):274-7. PubMed ID: 2099963
    [Abstract] [Full Text] [Related]

  • 7. [Heparan sulphate in association with indobufen in the treatment of chronic peripheral obliterative arteriopathy of the lower extremities. Controlled clinical trial].
    Rossini A, Tascino C, Costa F.
    Minerva Cardioangiol; 1998 Nov; 46(11):457-69. PubMed ID: 10207294
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

  • 9. Double-blind controlled study of the efficacy and pharmacological properties of heparan sulfate in patients with occlusive arterial disease of the lower limbs.
    Strano A, Pinto A, Galati D.
    Drugs Exp Clin Res; 1990 Mar; 16(10):543-50. PubMed ID: 2151628
    [Abstract] [Full Text] [Related]

  • 10. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F, Marubini E, Coccheri S, Nenci GG.
    Thromb Haemost; 2000 May; 83(5):672-7. PubMed ID: 10823260
    [Abstract] [Full Text] [Related]

  • 11. Effects of defibrotide on peripheral obliterative vascular diseases.
    Ulutin ON, Ilhan-Berkel N, Tunali H, Ozer M, Balkuv-Ulutin S, Onsel C, Urgancioğlu I.
    Haemostasis; 1986 May; 16 Suppl 1():59-62. PubMed ID: 3754837
    [Abstract] [Full Text] [Related]

  • 12. Effects of oral and intravenous defibrotide on blood viscosity in patients with peripheral obliterative arterial disease.
    Belfiglio A, Traietti P, Bologna E, Salvo G.
    Clin Ther; 1989 May; 11(4):479-84. PubMed ID: 2776165
    [Abstract] [Full Text] [Related]

  • 13. Treatment of intermittent claudication with defibrotide or mesoglycan. A double blind study.
    Laurora G, Ambrosoli L, Cesarone MR, De Sanctis MT, Incandela L, Marelli C, Belcaro G.
    Panminerva Med; 1994 Jun; 36(2):83-6. PubMed ID: 7831064
    [Abstract] [Full Text] [Related]

  • 14. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A.
    Ann Vasc Surg; 2008 Jun; 22(4):552-8. PubMed ID: 18502605
    [Abstract] [Full Text] [Related]

  • 15. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Jun; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 16. [Spinal electrostimulation in the treatment of advanced chronic obliterating arteriopathies].
    Visconti W, Fontana P, Buonocore P, Grillo N, Seno S.
    Minerva Cardioangiol; 1996 Jun; 44(1-2):19-27. PubMed ID: 8767618
    [Abstract] [Full Text] [Related]

  • 17. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G, Poggiali C, Calacoci S, Marino N, Rosselli A.
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Physical training and low-dose heparin-calcium in patients suffering from chronic obliterating arteriopathy of the lower limbs with intermittent claudication].
    Cina G, Vernich M, Campisi C, Cascone C, Ofria F, Leopardi N, Maniscalco G, Moricca N, Ceccarelli V, Paolicelli D, Carbone D.
    Minerva Cardioangiol; 1996 Apr; 44(4):179-85. PubMed ID: 8767599
    [Abstract] [Full Text] [Related]

  • 20. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
    Craveri A, Colombo L, Cristina M, Coloru M, De Angeli B, Lanfredini M.
    Clin Ter; 1991 Jan 15; 136(1):23-9. PubMed ID: 1826869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.